Canadian application, no grantCanada
Use of convertase inhibitors in the treatment of fibrosis and scarring
CA 2492331 A1 · Owner: Renovo Limited · Inventors: Ferguson, Mark William James; Brunner, Georg
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to use of convertase inhibitors for the reduction of scarring during the healing of wounds and also for reducing fibrosis in the treatment of fibrotic conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 23, 2003
GrantedNo grant recorded
Term endedJuly 23, 2023
Patent numberCA 2492331 A1
Classification (IPC)A61K38/55 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.